Fate Therapeutics Profit Margin

The latest profit margin for FATE is -1941.09% as of June 2026. That compares with -2025.05% in the prior-year period — up 4.1% year over year. That is below the Healthcare sector average of 10.58%. Investors often review this figure alongside Fate Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, FATE's profit margin moved from -2025.05% to -1941.09% — a 4.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Fate Therapeutics's valuation or profitability profile.

Against Healthcare companies, FATE currently prints -1941.09% for profit margin, while the sector average sits near 10.58%. That is roughly 18446.0% below the sector mean. Large gaps often invite a closer look at Fate Therapeutics's growth, margins, and balance sheet.

Profit Margin shows how effectively Fate Therapeutics converts resources into returns. At -1941.09%, FATE may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -2025.05% in the prior-year period — up 4.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting FATE's profit margin (-1941.09%), review year-over-year change from -2025.05%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.